Meridian Bioscience Inc. (VIVO): Price and Financial Metrics


Meridian Bioscience Inc. (VIVO): $19.25

0.18 (+0.94%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

VIVO POWR Grades


  • VIVO scores best on the Value dimension, with a Value rank ahead of 97.72% of US stocks.
  • VIVO's strongest trending metric is Momentum; it's been moving down over the last 206 days.
  • VIVO's current lowest rank is in the Stability metric (where it is better than 19.57% of US stocks).

VIVO Stock Summary

  • With a price/earnings ratio of 9.25, Meridian Bioscience Inc P/E ratio is greater than that of about only 15.12% of stocks in our set with positive earnings.
  • Over the past twelve months, VIVO has reported earnings growth of 261.65%, putting it ahead of 92.95% of US stocks in our set.
  • Revenue growth over the past 12 months for Meridian Bioscience Inc comes in at 60.36%, a number that bests 90.76% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to VIVO, based on their financial statements, market capitalization, and price volatility, are LAKE, CYBE, ADUS, CYAN, and SMP.
  • Visit VIVO's SEC page to see the company's official filings. To visit the company's web site, go to www.meridianbioscience.com.

VIVO Price Target

For more insight on analysts targets of VIVO, see our VIVO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $32.67 Average Broker Recommendation 1.25 (Strong Buy)

VIVO Stock Price Chart Interactive Chart >

Price chart for VIVO

VIVO Price/Volume Stats

Current price $19.25 52-week high $30.65
Prev. close $19.07 52-week low $12.98
Day low $19.09 Volume 488,100
Day high $19.68 Avg. volume 745,425
50-day MA $23.03 Dividend yield N/A
200-day MA $20.44 Market Cap 834.10M

Meridian Bioscience Inc. (VIVO) Company Bio


Meridian Biosciences is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. The company was founded in 1976 and is based in Cincinnati, Ohio.

VIVO Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$19.25$13.85 -28%

We started the process of determining a valid price forecast for Meridian Bioscience Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Meridian Bioscience Inc ranked in the 46th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Meridian Bioscience Inc ended up being:

  • VIVO's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 36.64% of tickers in our DCF set.
  • Meridian Bioscience Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 38.31. This coverage rate is greater than that of 89.6% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • As a business, Meridian Bioscience Inc experienced a tax rate of about 17% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 73.77% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-29%
1%-29%
2%-28%
3%-27%
4%-27%
5%-26%

Want more companies with a valuation profile/forecast similar to that of Meridian Bioscience Inc? See TMO, STE, REGN, SNY, and MEDP.


VIVO Latest News Stream


Event/Time News Detail
Loading, please wait...

VIVO Latest Social Stream


Loading social stream, please wait...

View Full VIVO Social Stream

Latest VIVO News From Around the Web

Below are the latest news stories about Meridian Bioscience Inc that investors may wish to consider to help them evaluate VIVO as an investment opportunity.

Cannabis Stock Gainers And Losers From May 13, 2021

GAINERS: Golden Leaf Holdings (OTC: GLDFF ) shares closed up 9.38% at $0.05 EnWave (OTC: NWVCF ) shares closed up 8.91% at $1.22 Gaby (OTC: GABLF ) shares closed up 6.35% at $0.09 Cipher Pharms Inc (OTC: CPHRF ) shares closed up 5.45% at $1.13 Indiva (OTC: NDVAF ) shares closed up 4.79% at $0.37 Meridian Bioscience (NASDAQ: VIVO ) shares closed up 3.22% at $18.59 World Acceptance (NASDAQ: WRLD ) shares closed up 2.97% at $142.77 MariMed (OTC: MRMD ) shares closed up 2.56% at $0.77 C21 Investments (OTC: CXXIF ) shares closed up 2.54% at $1.12 ESCO Technologies (NYSE: ESE ) shares … Full story available on Benzinga.com

Benzinga | May 13, 2021

Meridian Bioscience (VIVO) Outpaces Stock Market Gains: What You Should Know

Meridian Bioscience (VIVO) closed at $20.45 in the latest trading session, marking a +6.68% move from the prior day.

Yahoo | May 7, 2021

Meridian Bioscience Inc (VIVO) Q2 2021 Earnings Call Transcript

Image source: The Motley Fool. Meridian Bioscience Inc (NASDAQ: VIVO)Q2 2021 Earnings CallMay 7, 2021, 10:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood afternoon and thank you for standing by.

Yahoo | May 7, 2021

Meridian Bioscience (VIVO) Beats Q2 Earnings Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 16.67% and -2.26%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 7, 2021

Meridian Bioscience, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 7, 2021 / Meridian Bioscience, Inc. (NASDAQ:VIVO) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on May 7, 2021 at 10:00 AM Eastern Time.

Yahoo | May 7, 2021

Read More 'VIVO' Stories Here

VIVO Price Returns

1-mo -17.20%
3-mo -28.47%
6-mo 2.23%
1-year 27.06%
3-year 33.93%
5-year 14.18%
YTD 3.00%
2020 91.30%
2019 -43.29%
2018 28.02%
2017 -18.02%
2016 -9.91%

Continue Researching VIVO

Want to see what other sources are saying about Meridian Bioscience Inc's financials and stock price? Try the links below:

Meridian Bioscience Inc (VIVO) Stock Price | Nasdaq
Meridian Bioscience Inc (VIVO) Stock Quote, History and News - Yahoo Finance
Meridian Bioscience Inc (VIVO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8568 seconds.